{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T12:34:59Z","timestamp":1722774899463},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>BRAF inhibitors such as vemurafenib are a new family of biological drugs, recently available to treat metastatic malignant melanoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We present the case of a 38-year-old man affected by metastatic melanoma who had been under treatment with vemurafenib for a few days. The patient suffered from sudden onset of abdominal pain due to intra-abdominal hemorrhage with profuse hemoperitoneum. An emergency abdominal sonography confirmed the clinical suspicion of a splenic rupture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The intraoperative finding was hemoperitoneum due to splenic two-step rupture and splenectomy was therefore performed. Histopathology confirmed splenic hematoma and capsule laceration, in the absence of metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This report describes the occurrence of a previously unreported adverse event in a patient with stage IV melanoma receiving vemurafenib.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-10-155","type":"journal-article","created":{"date-parts":[[2012,7,30]],"date-time":"2012-07-30T12:14:29Z","timestamp":1343650469000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib"],"prefix":"10.1186","volume":"10","author":[{"given":"Elisa","family":"Castellani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Covarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Boselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cirocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barberini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Caracappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Desiderio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Burini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Noya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,30]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/bjs.6737","volume":"96","author":"P Renzulli","year":"2009","unstructured":"Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D: Systematic review of atraumatic splenic rupture. Br J Surg. 2009, 96: 1114-1121. 10.1002\/bjs.6737.","journal-title":"Br J Surg"},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajem.2007.11.003","volume":"26","author":"SJ Rhee","year":"2008","unstructured":"Rhee SJ, Sheena Y, Imber C: Spontaneous rupture of the spleen: a rare but important differential of an acute abdomen. Am J Emerg Med. 2008, 26: 733-","journal-title":"Am J Emerg Med"},{"key":"1118_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2165\/11591380-000000000-00000","volume":"71","author":"N Natarajan","year":"2011","unstructured":"Natarajan N, Telang S, Miller D, Chesney J: Novel immunotherapeutic agents and small molecule antagonists of signalling kinases for the treatment of metastatic melanoma. Drugs. 2011, 71: 1233-1250. 10.2165\/11591380-000000000-00000.","journal-title":"Drugs"},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322\/caac.20073.","journal-title":"CA Cancer J Clin"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1158\/1078-0432.CCR-10-0174","volume":"17","author":"A Vultur","year":"2011","unstructured":"Vultur A, Villanueva J, Herlyn M: Targeting BRAF in advanced melanoma: a first step toward manageable disease. Clin Cancer Res. 2011, 17: 1658-1663. 10.1158\/1078-0432.CCR-10-0174.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1118_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1066896911417970","volume":"20","author":"EH Kerr","year":"2012","unstructured":"Kerr EH, Hameed O, Lewis JS, Bartolucci AA, Wang D, Said-Al-Naief N: Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. Int J Surg Pathol. 2012, 20 (1): 37-46. 10.1177\/1066896911417970.","journal-title":"Int J Surg Pathol"},{"key":"1118_CR7","first-page":"233","volume":"82","author":"L Di Libero","year":"2011","unstructured":"Di Libero L, Sciascia V, Esposito D, Varriale R, Tartaglia E, Santini L: Surgical treatment of metastases from cutaneous melanoma to the small intestine and the spleen. Case reports and review of the literature. Ann Ital Chir. 2011, 82: 233-238.","journal-title":"Case reports and review of the literature. Ann Ital Chir"},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gerschenwald JE, Soong S, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC, Morton DL, Ross MI, Sober AJ, Sondak VK: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009, 27: 6199-6206. 10.1200\/JCO.2009.23.4799.","journal-title":"J Clin Oncol"},{"key":"1118_CR9","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O\u2019Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA: BRIM-3 Study Group: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011, 364: 2507-2516. 10.1056\/NEJMoa1103782.","journal-title":"N Engl J Med"},{"key":"1118_CR10","first-page":"s78","volume":"Suppl 1","author":"LA Pollack","year":"2011","unstructured":"Pollack LA, Li J, Berkowitz Z, Weir HK, Wu XC, Ajani UA, Ekwueme DU, Li C, Pollack BP: Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011, Suppl 1: s78-86.","journal-title":"J Am Acad Dermatol"},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00105-011-2232-8","volume":"62","author":"C Hafner","year":"2011","unstructured":"Hafner C: Therapie des metastasierten Melanoms mit BRAF-Inhibitoren. Hautarzt. 2011, 62: 696-698. 10.1007\/s00105-011-2232-8.","journal-title":"Hautarzt"},{"issue":"5","key":"1118_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1468-3083.2011.04109.x","volume":"26","author":"F Rondelli","year":"2012","unstructured":"Rondelli F, Vedovati MC, Becattini C, Tomassini GM, Messina S, Noya G, Simonetti S, Covarelli P: Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. J Eur Acad Dermatol Venereol. 2012, 26 (5): 560-565. 10.1111\/j.1468-3083.2011.04109.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jso.22034","volume":"104","author":"O Hamid","year":"2011","unstructured":"Hamid O, Boasberg PD, Rosenthal K, O\u2019Day SJ: Systemic treatment of metastatic melanoma: New approaches. J Surg Oncology. 2011, 104: 425-429.","journal-title":"J Surg Oncology"},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-09-3064","volume":"16","author":"CA Pratilas","year":"2010","unstructured":"Pratilas CA, Solit DB: Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clin Cancer Res. 2010, 16: 3329-3334. 10.1158\/1078-0432.CCR-09-3064.","journal-title":"Clin Cancer Res"},{"key":"1118_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature09454","volume":"467","author":"G Bollag","year":"2010","unstructured":"Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang Y, Habets G, Burton EA, Wong B, Tsang G, West BL, Powell B, Shellooe R, Marimuthu A, Nguyen H, Zhan KY, Artis DR, Schlessinger J, Su F, Higgins B, Iyer R, D\u2019Andrea K, Koehler A, Stumm M, Lin PS, Lee RJ, Grippo J, Puzanov I: Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF- mutant melanoma. Nature. 2010, 467: 596-599. 10.1038\/nature09454.","journal-title":"Nature"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","volume":"104","author":"HT Arkenau","year":"2011","unstructured":"Arkenau HT, Kefford R, Long GV: Targeting BRAF for patients with melanoma. Br J Cancer. 2011, 104: 392-398. 10.1038\/sj.bjc.6606030.","journal-title":"Br J Cancer"},{"key":"1118_CR17","doi-asserted-by":"publisher","first-page":"42409","DOI":"10.1074\/jbc.M308709200","volume":"278","author":"A Calipel","year":"2003","unstructured":"Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychene A, Mascarelli F: Mutation of B-Raf in Human choroidal melanoma cells mediates cell proliferation and transformation through the MEK\/ERK pathway. J Biol Chem. 2003, 278: 42409-42418. 10.1074\/jbc.M308709200.","journal-title":"J Biol Chem"},{"key":"1118_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd J, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J: Mutations of the BRAF gene in human cancer. Nature. 2002, 417: 949-954. 10.1038\/nature00766.","journal-title":"Nature"},{"key":"1118_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O\u2019Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010, 363: 809-819. 10.1056\/NEJMoa1002011.","journal-title":"N Engl J Med"},{"key":"1118_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1200\/JCO.2011.36.7680","volume":"30","author":"PA Oberholzer","year":"2012","unstructured":"Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, Macconaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA: RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol. 2012, 30: 316-321. 10.1200\/JCO.2011.36.7680.","journal-title":"J Clin Oncol"},{"key":"1118_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1105358","volume":"366","author":"F Su","year":"2012","unstructured":"Su F, Viros A, Milagre C, Trunzer K, Bollag G, Spleiss O, Reis-Filho JS, Kong X, Koya RC, Flaherty KT, Chapman PB, Kim MJ, Hayward R, Martin M, Yang H, Wang Q, Hilton H, Hang JS, Noe J, Lambros M, Geyer F, Dhomen N, Niculescu-Duvaz I, Zambon A, Niculescu-Duvaz D, Preece N, Robert L, Otte NJ, Mok S, Kee D: RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med. 2012, 366: 207-15. 10.1056\/NEJMoa1105358.","journal-title":"N Engl J Med"},{"key":"1118_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","volume":"464","author":"PI Poulikakos","year":"2010","unstructured":"Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N: RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature. 2010, 464: 427-30. 10.1038\/nature08902.","journal-title":"Nature"},{"key":"1118_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","volume":"140","author":"SJ Heidorn","year":"2010","unstructured":"Heidorn SJ, Milagre C, Whittaker S, Nourry A, Niculescu-Duvas I, Dhomen N, Hussain J, Reis-Filho JS, Springer CJ, Pritchard C, Marais R: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell. 2010, 140: 209-21. 10.1016\/j.cell.2009.12.040.","journal-title":"Cell"},{"issue":"15","key":"1118_CR24","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1200\/jco.2010.28.15_suppl.2503","volume":"28","author":"JR Infante","year":"2010","unstructured":"Infante JR, Fecher LA, Nallapareddy S, Gordon MS, Flaherty KT, Cox DS, DeMarini DJ, Morris SR, Burris HA, Messersmith WA: Safety and efficacy results from the first-in-human study of the oral MEK 1\/2 inhibitor GSK1120212. J Clin Oncol. 2010, 28 (15): 2503-","journal-title":"J Clin Oncol"},{"key":"1118_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1056\/NEJMe1111636","volume":"366","author":"AT Weeraratna","year":"2012","unstructured":"Weeraratna AT: RAF around the Edges - The Paradox of BRAF Inhibitors. N Engl J Med. 2012, 366: 271-273. 10.1056\/NEJMe1111636.","journal-title":"N Engl J Med"},{"key":"1118_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09626","volume":"468","author":"R Nazarian","year":"2010","unstructured":"Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H, Chodon T, Nelson SF, McArthur G, Sosman JA, Ribas A, Lo RS: Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010, 468: 973-977. 10.1038\/nature09626.","journal-title":"Nature"},{"key":"1118_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","volume":"18","author":"J Villanueva","year":"2010","unstructured":"Villanueva J, Vultur A, Lee JT, Somasundaram R, Fukunaga-Kalabis M, Cipolla AK, Wubbenhorst B, Xu X, Gimotty PA, Kee D, Santiago-Walker AE, Letrero R, D\u2019Andrea K, Pushparajan A, Hayden JE, Brown KD, Laquerre S, McArthur GA, Sosman JA, Nathanson KL, Herlyn M: Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K. Cancer Cell. 2010, 18: 683-695. 10.1016\/j.ccr.2010.11.023.","journal-title":"Cancer Cell"},{"key":"1118_CR28","first-page":"1","volume":"106","author":"MJ Orloff","year":"1958","unstructured":"Orloff MJ, Peskin GW: Spontaneous rupture of the normal spleen: a surgical enigma. Int Abstr Surg. 1958, 106: 1-11.","journal-title":"Int Abstr Surg"},{"key":"1118_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1572-0241.1999.00820.x","volume":"94","author":"K Sugahara","year":"1999","unstructured":"Sugahara K, Togashi H, Aoki M, Mitsuhashi H, Matsuo T, Watanabe H, Abe T, Ohno S, Saito K, Saito T, Shinzawa H, Tanida H, Ito M, Takahashi T: Spontaneous splenic rupture in a patient with large hepatocellular carcinoma. Am J Gastroenterol. 1999, 94: 276-278. 10.1111\/j.1572-0241.1999.00820.x.","journal-title":"Am J Gastroenterol"},{"key":"1118_CR30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.5858\/2004-128-1146-SRARPO","volume":"128","author":"WM Smith","year":"2004","unstructured":"Smith WM, Lucas JG, Frankel WL: Splenic rupture: a rare presentation of pancreatic carcinoma. Arch Pathol Lab Med. 2004, 128: 1146-1150.","journal-title":"Arch Pathol Lab Med"},{"key":"1118_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/1752-1947-5-444","volume":"5","author":"A Kyriacou","year":"2011","unstructured":"Kyriacou A, Arulai N, Varia H: Acute abdomen due to spontaneous splenic rupture as the first presentation of lung malignancy: a case report. J Med Case Reports. 2011, 5: 444-10.1186\/1752-1947-5-444.","journal-title":"J Med Case Reports"},{"key":"1118_CR32","first-page":"674","volume":"76","author":"CP Karakousis","year":"1974","unstructured":"Karakousis CP, Elias EG: Spontaneous (pathologic) rupture of spleen in malignancies. Surgery. 1974, 76: 674-677.","journal-title":"Surgery"},{"key":"1118_CR33","first-page":"630","volume":"126","author":"RH Richter","year":"2001","unstructured":"Richter RH, Reingruber B, Gr\u00fcneis C, Altendorf-Hofmann A, Rupprecht H: Spontaneous splenic rupture in metastatic malignant melanoma. Chir. 2001, 126: 630-631.","journal-title":"Chir"},{"key":"1118_CR34","first-page":"47","volume":"78","author":"TM Buzbee","year":"1992","unstructured":"Buzbee TM, Legha SS: Spontaneous rupture of spleen in a patient with splenic metastasis of melanoma. A case report. Tumori. 1992, 78: 47-48.","journal-title":"A case report. Tumori"},{"key":"1118_CR35","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-04-2423","volume":"65","author":"A Sharma","year":"2005","unstructured":"Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GB: Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res. 2005, 65: 2412-10.1158\/0008-5472.CAN-04-2423.","journal-title":"Cancer Res"},{"key":"1118_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1073\/pnas.1105026109","volume":"109","author":"A Bottos","year":"2012","unstructured":"Bottos A, Martini M, Di Nicolantonio F, Comunanza V, Maione F, Minassi A, Appendino G, Bussolino F, Bardelli A: Targeting oncogenic serine\/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia. PNAS. 2012, 109: 353-359. 10.1073\/pnas.1105026109.","journal-title":"PNAS"},{"key":"1118_CR37","first-page":"4575","volume":"55","author":"J Rak","year":"1995","unstructured":"Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS: Mutant ras oncogenes upregulate VEGF\/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995, 55: 4575-4580.","journal-title":"Cancer Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-10-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:21:23Z","timestamp":1630527683000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-10-155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-10-155","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,30]]},"assertion":[{"value":"20 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"155"}}